Navigation Links
Faces of Mesothelioma; Meso Foundation Press Conference with Families and Patients

WASHINGTON, June 24 /PRNewswire/ -- With a latency period of 10-50 years, and with millions of Americans at risk for mesothelioma, an asbestos-generated cancer, the ravages of this life ending disease continue to disrupt families and lives. The Meso Foundation is hosting a press conference with leadership, members of Congress and three guest speakers who will share their poignant stories of loss due to mesothelioma.

The press conference will be held on the first day of the three-day 5th Annual International Symposium on Malignant Mesothelioma, sponsored by the Mesothelioma Applied Research Foundation (Meso Foundation), an event that offers information, support and awareness to help insure the banning of asbestos and increased dollars for meso research.

Where: Hyatt Regency Washington on Capitol Hill

The Lexington Conference Room, Ballroom Level

400 New Jersey Avenue N.W.

Washington, DC 20001

(202) 737-1234

When: Thursday, June 26, 2008

3:00 pm - 4:00 pm

What: This press conference hosted by the Meso Foundation kicks off the

first day of the three day International Symposium on Malignant

Mesothelioma. The press conference is focused on the

intergenerational impact of mesothelioma, with the three guest

speakers: 12 year old, Lexi Miletto, whose grandfather died of

meso in 2005; Taylor Stoeckler, 15 years old, whose father died of

meso in 2007; and, Julie Gundlach, a young mother who has been

diagnosed with meso.

Why: Asbestos is a known carcinogen, to which millions of Americans are

unwittingly exposed each year. The damaging effects of asbestos do

not manifest until decades after exposure -- most often occurring

as malignant mesothelioma. In the past eight years since the Meso

Foundation has begun working on getting legislation passed, each

year 3000 people have died of meso and tens of thousands have been

exposed to asbestos. This press conference highlights the

continued tragedy of meso and the desperate need for more research

funding to help all those affected by this disease.

For more information or to arrange interviews with International Symposium on Malignant Mesothelioma participants, please contact Chris Hahn at (805) 252-8955 or Joel Schnur at (917) 647-2249 or

Speakers will be available for photo ops and interviews.

Program overview can be found at:

SOURCE Meso Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Bill Allowing Medical Privacy Intrusion Fails in Sacramento; Anti-Privacy Bill by Auto Insurers Faces Vote Wednesday
2. Faces May Provide Clues to Sexual Attitudes
3. Four Rivers Software Systems and ECRI Institute Announce New, Real-Time Interfaces to Improve Inventory Management and Patient Safety Alert and Recall Tracking
4. NJHA: State Faces Access-to-Care Crisis
5. Successful Massachusetts Healthcare Reform Initiative Faces Rising Healthcare Costs in Year Two
6. On Valentines Day, Abbott Urges Women to Take Heart With Launch of Faces of Heart Disease Exhibit to Raise Heart Health Awareness
7. Distributes Key Findings on Global Specialty Medical Beds and Therapeutic Surfaces Market
8. MediNotes EMR Now Interfaces With 76 Practice Management Systems, Allowing More Medical Practices to Replace Their Patients Aging Paper Medical Records
9. US-Based Bollywood On-Demand Service to Sponsor Faces of India YouthAIDS Gala on November 2nd
10. Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit
11. MIKE AND IKE(R) Lemonade Blends(TM) Presents $100,000 to Alexs Lemonade Stand Foundation
Post Your Comments:
(Date:10/10/2015)... York, NY (PRWEB) , ... October 10, 2015 , ... ... some alarming numbers on the growth of cybercrime costs for US companies. The New ... on Tuesday, October 6th. With averages showing increases hovering around 20% among the companies ...
(Date:10/10/2015)... , ... October 10, 2015 , ... Isabel Healthcare will ... , On the heels of the release of the Institute of Medicine’s latest report ... their integration with Cerner solutions that assist healthcare providers and consumers to potentially reduce ...
(Date:10/9/2015)... ... October 09, 2015 , ... The American Osteopathic ... for Graduate Medical Education J. Michael Finley, DO, as the recipient of the ... for his impact on graduate medical education opportunities for osteopathic residents, and his ...
(Date:10/9/2015)... ... 2015 , ... A new health tool that helps identify if a sore ... ) – just in time for the cold and flu season, which the ... many in the U.S., the real start of cold/flu season is the start of ...
(Date:10/9/2015)... ... October 09, 2015 , ... Dentist in Huntington ... orthodontic system that uses clear, plastic aligners. This alternative to braces has become ... which allow patients to complete treatment in privacy. Additionally, Invisalign aligners are removable, ...
Breaking Medicine News(10 mins):
... serious problem that can often be fatal. Methadone has ... addicts. However, the major concern in treating heroin addicts ... is one reason methadone therapy is usually only given ... that an alternative drug therapy combined with psychosocial treatment ...
... researchers are currently testing the safety of hypothermia ... injury. Hypothermia treatment has been shown to be ... but its effectiveness in treating children with traumatic ... decreases inflammation, excitotoxicity (excessive neurotransmitters released with injury ...
... of skin cancer and it has been shown through previous ... sunlight, whose UV rays cause damage to DNA that triggers ... are more prone than others to melanoma. Researchers have now ... people with melanoma that those with fair skin// have lowered ...
... Affective Disorder(SAD) is not all that well understood, but ... sunlight in the winter months. Winter depression involves suffering ... days get longer and nights get shorter. Other SAD ... sleeping for longer than usual. Researchers have now found ...
... hospital in Kolkatta, India recently received a patient, a two-month-old ... suffering from a rare disease caused due to a deficiency ... of 10 million children. Doctors said that the baby was ... On detection the baby, a boy child, was found to ...
... time to its ultraviolet rays, has always been said to be ... shown that even moderate sun exposure can result in moles that ... to sun has been shown as the main risk factor for ... rarest type of skin cancer, is much weaker. It has however, ...
Cached Medicine News:
(Date:10/8/2015)... Oct. 8, 2015  Clariant, a world leader in specialty ... facility in Belen, New Mexico , has ... including desiccant canisters and packets and other ... plant is the second Clariant site – the first in ... the ISO 15378:2011 standards, following only the Clariant manufacturing facility ...
(Date:10/8/2015)... , Oct. 8, 2015  Nektar Therapeutics (Nasdaq: ... pain and oncology portfolio during an Investor and Analyst ... p.m. Eastern Time in New York City ... of the NKTR-214 Phase 1/2 clinical program and biomarker ... cytokine designed to preferentially stimulate the production of CD8-positive ...
(Date:10/8/2015)... a clinical stage drug development company focused on advancing ... today the commencement of the US arm of an ... acebilustat, in patients with cystic fibrosis (CF). The study ... the United States and European Union, ... 2016. This landmark clinical trial testing once-daily oral acebilustat ...
Breaking Medicine Technology:
... Texas, Dec. 2, 2010 Ascension Orthopedics, Inc., ... another implantation of the TITAN™ Modular Total Shoulder. ... at Bucks County Specialty Hospital in Bensalem, Pennsylvania. ... postoperative x-rays showed a very anatomic replacement.  The ...
... 2, 2010 Medical devices, biotechnology and IT products ... will present to United States investors and the business ... business and investment opportunities. (Logo: ... successful Chilean Small and Medium Enterprises (SMEs) was selected ...
Cached Medicine Technology:
The IRN method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of iron in serum....
For the quantitative in vitro determination of Aspartate Aminotransferase (AST) in serum and plasma....
Enzymatic Clearance assay for the in vitro quantitative determination of HDL-cholesterol in human serum and plasma....
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
Medicine Products: